Business
Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in May
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the
About this update from Dianthus Therapeutics, Inc.
[{"type":"text","content":" CAMBRIDGE, Mass.--(BUSINESS WIRE)--\nMagenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that Jason Gardner, D.Phil., President and Chief Executive Officer, will participate in fireside chats at the following investor conferences this month:\n\n\nCowen 2nd Annual Virtual Oncology Innovation Summit on Thursday, May 20, at 10:40 a.m. ET\n\n\nOppenheimer Rare & Orphan Disease Summit on Friday, May 21, at 2:55 p.m. ET\n\n\nLive webcasts of the fireside chats can be accessed on the Magenta Therapeutics website at https://investor.magentatx.com/events-and-presentations. The webcast replays will be available for 90 days following each event.\n\nAbout Magenta Therapeutics\n\nMagenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.\n\nMagenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.\n\nFollow Magenta on Twitter: @magentatx.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005057/en/\n\nMagenta Therapeutics\nJim Haney, Senior Director, Investor Relations\n317-909-4199\[email protected]\n\nLyndsey Scull, Director, Corporate Communications\n202-213-7086\[email protected]\n\nJill Bertotti, Real Chemistry\n714-225-6726\[email protected]\n\nSource: Magenta Therapeutics","length":3924,"tagName":"div"}]